CAT
Caterpillar Inc.
CAT has the edge over TPCS overall, supported by stronger fundamentals.
TPCS
TechPrecision Corporation
TPCS offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
TPCS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Under pressure | |
| Stable |
TPCS's revenue, profitability and balance sheet are currently stable, but its cash flow is under pressure.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
TPCS PE Valuation
TPCS has no meaningful PE right now: it lost money over the past year.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
TPCS Forward outlook
There aren't enough analyst estimates for TPCS to show an outlook.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $29.73 | +17% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the edge over TPCS on earnings quality, reporting a profit while its opponent remains loss making.
TPCS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.13 | +$0.06 |
| Q1 2026 | -$0.17 | +$0.12 |
| Q4 2025 | -$0.12 | +$0.77 |
| Q3 2025 | -$0.05 | +$0.86 |
| Q2 2025 | -$0.19 | +$0.72 |
| Q1 2025 | -$0.29 | +$0.52 |
| Q4 2024 | -$0.89 | -$0.56 |
| Q3 2024 | -$0.91 | -$0.68 |
TPCS is still losing money, but far less than before: $0.13 per share over the past year, against $0.91 at its worst in mid-2024.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT has the edge over TPCS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over TPCS on profitability, with a higher operating margin.
TPCS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $9.1M | +23% |
| Q1 2026 | $8.1M | -15% |
| Q4 2025 | $7.1M | -6.9% |
| Q3 2025 | $9.1M | +1.6% |
| Q2 2025 | $7.4M | -7.6% |
| Q1 2025 | $9.5M | +10% |
| Q4 2024 | $7.6M | -0.4% |
| Q3 2024 | $8.9M | +12% |
TPCS's revenue grew through 2024 and has held roughly level since: $9M last quarter, up 23% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -0.5% | +5.8 points |
| Q1 2026 | -2.4% | -6.3 points |
| Q4 2025 | -19% | -9.9 points |
| Q3 2025 | 10% | +16 points |
| Q2 2025 | -6.3% | +11 points |
| Q1 2025 | 3.9% | +33 points |
| Q4 2024 | -9.1% | +3.9 points |
| Q3 2024 | -5.5% | +2 points |
TPCS's operating margin was −0.5% last quarter, up 5.8 points from the same quarter a year ago.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT has the edge over TPCS on cash generation, producing positive trailing cash flow while its opponent burns cash.
TPCS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$538K | +$66K |
| Q1 2026 | $249K | +$1.2M |
| Q4 2025 | -$827K | +$917K |
| Q3 2025 | -$2.1M | -$123.8K |
| Q2 2025 | -$604K | -$510.2K |
| Q1 2025 | -$930K | -$607.4K |
| Q4 2024 | -$1.7M | -$1.5M |
| Q3 2024 | -$2M | -678% |
TPCS has burned cash in most quarters: −$3M over the past year, against −$5M the year before.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over TPCS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
TPCS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.9% | +187K shares |
| 1 year | +3.5% | +342K shares |
| 3 years | +17% | +1.5M shares |
| 5 years | +30% | +2.3M shares |
| Available history | +38% | +2.8M shares |
TPCS has 10M diluted shares, up 3.5% from a year ago.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has the edge over TPCS on leverage, with a lower net debt burden relative to earnings.
TPCS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 2.1x | Moderate |
| Q1 2026 | 3.7x | Elevated |
| Q4 2025 | 2.9x | Moderate |
| Q3 2025 | 2.4x | Moderate |
| Q2 2025 | 3.7x | Elevated |
| Q1 2025 | 11.2x | High |
| Q3 2023 | 11.5x | High |
| Q2 2023 | 6.8x | High |
TPCS's net debt is about 2.1 years of its operating earnings (EBITDA), down from 3.7 years a year ago.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
TPCS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.0 | Neutral |
| Stochastic | 32.9 | Neutral |
TPCS's weekly RSI is 53 (neutral) and its Stochastic is 33 (neutral).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.1% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
TPCS PE vs Industrials Sector
| Metric | TPCS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
TPCS has no meaningful PE right now: it lost money over the past year.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 37% above its 200-week average.
TPCS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.30 | 1.7% below |
| 20 week MA | $5.27 | 1.1% below |
| 50 week MA | $4.58 | 14% above |
| 100 week MA | $4.23 | 23% above |
| 200 week MA | $4.89 | 6.5% above |
TPCS has the edge over CAT on trend strength, trading above more of its moving averages.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has finished every year since 2020 higher, and it's up 3.8% so far in 2026.
TPCS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6.88 | $5.40 | -22% |
| 2021 | $5.40 | $8.04 | +49% |
| 2022 | $8.04 | $6.52 | -19% |
| 2023 | $6.52 | $5.18 | -21% |
| 2024 | $5.18 | $3.89 | -25% |
| 2025 | $3.89 | $4.88 | +25% |
| 2026 YTD | $4.88 | $5.21 | +6.8% |
TPCS has the edge over CAT on returns for 2026, with the stronger performance.